Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
NRG Oncology
UNC Lineberger Comprehensive Cancer Center
Mayo Clinic
National Cancer Institute (NCI)
NRG Oncology
Washington University School of Medicine
Eastern Cooperative Oncology Group
University of Texas Southwestern Medical Center